Next Article in Journal
Populations of Heterodera schachtii Differ in Susceptibility to Rhizosphere Bacteria Structured by Plant Age
Previous Article in Journal
Natural Phenolics Disrupt Microbial Communication by Inhibiting Quorum Sensing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Trichosporon asahii: A Potential Growth Promoter for C. gallinacea? Implications for Chlamydial Infections and Cell Culture

1
University Paris-Est, French Agency for Food, Environmental and Occupational Health & Safety (Anses), Animal Health Laboratory, Bacterial Zoonoses Unit, 94700 Maisons-Alfort, France
2
Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Specialistic Virology Unit, 10154 Torino, Italy
3
Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong
4
Servizio Veterinario ASL TO5, S.C. Sanità Animale, 10023 Chieri, Italy
5
Anses, INRAE, Ecole Nationale Vétérinaire d’Alfort, UMR BIPAR, Laboratoire de Santé Animale, 94700 Maisons-Alfort, France
6
University Paris-Est, Anses, Animal Health Laboratory, Epidemiological Unit, 94700 Maisons-Alfort, France
7
Friedrich-Loeffler-Institut (FLI) (Federal Research Institute for Animal Health), Institute of Molecular Pathogenesis, 07743 Jena, Germany
8
RNA Bioinformatics and High-Throughput Analysis, Friedrich-Schiller-Universität Jena, 07743 Jena, Germany
*
Author to whom correspondence should be addressed.
Microorganisms 2025, 13(2), 288; https://doi.org/10.3390/microorganisms13020288
Submission received: 23 December 2024 / Revised: 20 January 2025 / Accepted: 21 January 2025 / Published: 27 January 2025
(This article belongs to the Section Veterinary Microbiology)

Abstract

:
The cultivation of Chlamydia gallinacea, a recently identified species, is challenging due to the lack of an optimized protocol. In this study, several infection protocols were tested, including different cell lines, incubation temperatures, centrifugation methods and culture media. However, none were successful in field samples. The only exception was a chance co-culture with Trichosporon asahii, a microorganism commonly found in the chicken gut. This suggests that current in vitro methods may not be optimized for this species and that host-associated microorganisms may influence the in vivo growth of C. gallinacea, which is typically found in the chicken gut. These findings raise new questions and highlight the need for further investigation of microbial interactions within the host, particularly to understand their role in the proliferation of chlamydial species.

Short Communication

Chlamydiae are Gram-negative bacteria that are obligate intracellular parasites with a unique life cycle in which extracellular infectious elementary bodies facilitate dissemination while intracellular non-infectious reticulate bodies are responsible for replication. The family Chlamydiaceae comprises two genera (Chlamydia and Chlamydiifrater) and 11 species within the genus Chlamydia, some of which cause infections in humans and animals [1]. C. gallinacea is widely distributed in poultry [2] and has recently been detected in poultry farmers, suggesting a potential risk of bird-to-human transmission [3].
In vitro growth of chlamydiae depends on suitable conditions for the attachment of elementary bodies to host cell membranes and a favourable intracellular environment for bacterial development. Various methods have been used to optimize chlamydial growth protocols, such as the chemical or physical treatment of cell cultures, incubation temperature optimization, and specific cell lines [4,5]. However, some chlamydial strains and species remain difficult to cultivate, such as C. suis from pigs [6,7], C. pecorum from the ruminant intestinal tract, C. psittaci from non-avian sources [8], and C. pneumoniae from human respiratory specimens [9].
The first isolates of C. gallinacea were obtained from cloacal swabs of chickens in France using chicken embryos as a culture method [10]. One of these isolates (08-1274/3) was propagated in the BGM cell line to study its ultrastructural and molecular characteristics [11]. However, in subsequent studies in different laboratories, the infectivity tended to decrease with each passage in chicken embryos or BGM cells, with small diffuse inclusions observed by immunofluorescence in some laboratories, leading to strain loss (unpublished data).
The aim of this study was to test different culture conditions for isolating C. gallinacea from field samples, using immunofluorescence to visualize well-formed inclusions. This method reliably detects chlamydial inclusions in cultured cells, allowing for the assessment of strain viability and further detailed strain characterization.
A standard protocol involving immunofluorescence labelling is commonly used for the isolation of Chlamydiaceae [12]. Briefly, after inoculation, the BGM cell monolayers were centrifuged at 3000× g for 1 h at 37 °C, followed by 2 h at 37 °C in 5% CO2. The cell growth medium was replaced with serum-free UltraMDCK supplemented with 1% non-essential amino acids, 1% vitamins and antibiotics/antifungals (25 µg/mL of vancomycin, 10 µg/mL of gentamycin, 2.5 µg/mL of amphotericin B and 25 U/mL of nystatin). This medium was changed after 24 h, and the infected cells were then incubated at 37 °C without CO2. Inclusions are usually visualized 48 h post-infection (pi) by immunostaining using the IMAGEN Chlamydia kit (Oxoid Ltd., Cambridgeshire, UK). Up to two passages were performed by collecting an infected vial at 48 h pi, freezing at −80 °C, sonication (sonication amplitude 80%, 0.8 s 10 cycles and 0.2 s pause between each cycle), and reinoculating 100 µL into a new vial containing fresh BGM cells.
We applied this protocol to four C. gallinacea-positive cloacal samples from Mexican poultry farms (A1, A8, Pue6-6 and Pue6-7, Table 1) [13]. However, cultivation resulted in poorly formed inclusion-like structures that were lost after subsequent passages (Figure 1).
To optimize the culture of C. gallinacea, we made specific modifications to the standard protocol and tested them on the C. gallinacea reference strain 08-1274/3_08DC63, which was initially grown on chicken embryos at Anses (Maisons-Alfort) and successfully propagated on cell lines at FLI (Jena). An overview of the optimization experiments is shown in Figure A1. The modified parameters included the cell lines (Experiment 1), the incubation temperature (Experiment 2), and the addition of a daily centrifugation step (Experiment 3).
Experiment 1: BGM (ATCC PTA-4594), DF-1 (ATCC CRL-3586), and Caco-2 (ATCC HTB-37) cell lines were compared. DF-1, derived from chicken embryo fibroblasts, shows higher mitochondrial function and faster division than other fibroblasts. Caco-2, derived from a colon adenocarcinoma, is intestinal. The aim of this comparison was to identify the best cell line for C. gallinacea, given its intestinal tropism in birds. The culture conditions for these three cell lines are described in Table A1. The susceptibility of these cell lines to infection was assessed using the titrated C. gallinacea strain 08-1274/3_08DC63 (7.3 × 107 IFU/mL). Well-defined chlamydial inclusions were observed in infected cells at 48 h pi with all cell lines. After passage, the size of the chlamydial inclusions varied between the cell lines, with Caco-2 cells showing larger inclusions than the other two cell lines. BGM cells showed chlamydial inclusions that were still visible after several days of infection in a nearly intact cell monolayer, whereas cell detachment was observed in DF-1 and Caco-2 cultures, probably due to a fast cell growth rate and the production of overlapping layers compared to BGM cells (Figure A2). Unfortunately, these cells detached during immunostaining, resulting in holes in the cultures and the loss of the immunofluorescence signal. Therefore, we decided to conserve the BGM cells in our experimental protocol.
Experiment 2: The effect of incubation temperature on inclusion formation was investigated because some chlamydial species, such as C. poikilothermis, have been shown to grow better at temperatures similar to those found in their natural hosts [17]. As birds have a natural temperature range between 38 °C and 43 °C, and to avoid exceeding the temperature limit set for BGM cells, we tested the C. gallinacea culture derived from Experiment 1 at 37 °C and 39 °C. When comparing these two incubation temperatures, we did not observe any difference in the growth of C. gallinacea, so we decided to maintain a temperature of 37 °C in our experimental protocol, as this is the classical temperature used for the cultivation of the Chlamydiaceae on this cell line.
Experiment 3: The addition of a daily centrifugation step instead of a single centrifugation was tested in our protocol, as this has been shown to improve the culture of C. pneumoniae [18], by promoting the chlamydial attachment to the cells. For this, BGM cells were infected with the C. gallinacea culture derived from Experiment 1 and incubated at 37 °C for up to 7 days. Countless inclusion-like, irregularly sized, bright green chlamydial structures were observed in the cytoplasm of infected cells, with no visible difference in C. gallinacea growth between the two protocols used (up to 168 h pi) (Figure A3). As this experiment showed no negative effect of daily centrifugation on C. gallinacea cultures, we decided to include this step in our protocol without renewing the culture medium, as it may have facilitated the entry of the Chlamydiaceae into the cells.
The comparison of different parameters (Experiments 1–3) for the growth of the C. gallinacea strain 08-1274/3_08DC63 showed no significant changes in inclusion formation compared to the standard protocol. We therefore decided to maintain the BGM cells at 37 °C with daily centrifugation. As a final approach, we tested an enriched culture medium inspired by Donati and colleagues [4] for direct application to field samples. After inoculation and centrifugation, the cell culture medium was replaced with EMEM supplemented with glucose, L-glutamine, cycloheximide and 20% of fetal calf serum (Table A2). This alternative protocol required CO2 incubation after medium replacement.
As the four positive Mexican cloacal swabs were not available for further cultivation attempts, the alternative protocol was applied to four freshly collected C. gallinacea-positive samples obtained from cloacal swabs of chickens from Italy [3]. These samples were collected in duplicate, with one sample tested by PCR and the second stored in preservation buffer at −80 °C until processing (Table 1). After their inoculation, immunostaining performed at 48 h pi showed innumerable inclusion-like, irregularly sized, bright green chlamydial structures in the cytoplasm of cells infected with all Italian samples, comparable to the results for Mexican samples using the standard protocol. Immunostaining of the first passages showed minimal differences in C. gallinacea growth in three of the four samples (41645-5, 44638-9, and 67320-6) (Figure 1), as seen in the Mexican samples using the standard protocol. However, one sample (60260-3) showed atypical development of chlamydial growth, with a few medium-sized, well-defined, light-green chlamydial inclusions observed at 48 h pi during the first passage. All samples were subcultured according to the normal procedure, and the chlamydial growth of all but one sample showed a pattern similar to that of the Mexican samples. In fact, only in sample 60260-3 were there several large, well-defined and light-green typical chlamydial inclusions observed, occupying almost the entire cell cytoplasm at 48 h pi of the second passage (Figure 1). The presence of C. gallinacea in sample 60260-3 was confirmed by real-time PCR [15]. Interestingly, the culture was found to be co-infected with a fungus, with macroscopically observable hyphal-like structures present within the first 24 h pi (Figure 2). Despite the renewal of the chlamydial infection medium (with antibiotics and amphotericin B) every 24 h and the passages, the fungal contamination persisted even after the addition of a fourfold concentration of antifungals to the culture medium. The fungus was grown on Sabouraud agar (Figure 2) and then identified as the dimorphic yeast Trichosporon asahii by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Trichosporon species are common in nature, with isolates obtained from various sources such as soil, wood, water bodies, animals, and birds [19]. In chickens, Microascus sp., Trichosporon spp., and Aspergillus spp. account for more than 80% of the total fungal population diversity, with T. asahii being the predominant species within the genus Trichosporon [20]. The detection of Trichosporon spp. in the culture of an atypically growing C. gallinacea isolate raises questions about its effect on the growth of this chlamydial strain. Co-infections of certain microorganisms with Chlamydia have been shown to have synergistic effects that may be beneficial to one or both pathogens, or prevent the growth of one pathogen by another. Previous studies have reported natural chlamydial co-infections with other viral and bacterial pathogens in birds [21,22,23]. A recent study has shown that the biofilm formed by Candida albicans may favour the survival of C. trachomatis within it, thereby maintaining its infectious properties [24]. This biofilm provides a protective environment that reduces chlamydial susceptibility to antibiotics and promotes evasion of the host immune system. Several Trichosporon species, including Trichosporon asahii, are capable of producing highly resistant biofilms [25]. In humans, co-infections with Trichosporon have been reported, mainly in immunocompromised patients, in association with other viruses or bacteria [26,27,28].
Trichosporon asahii and its metabolites could also potentially interfere with chlamydial growth at several levels, such as activating chlamydial genes, providing nutrients necessary for chlamydial growth (e.g., energy molecules and/or co-factors), or facilitating chlamydial penetration into the cell. Indeed, Trichosporon is known to produce and secrete enzymes such as proteases and phospholipases that scavenge nutrients from the environment or facilitate the invasion process into various host tissues [19]. Trichosporon also expresses the immunomodulatory polysaccharide glucuronoxylomannan (GXM) in its cell wall, which is composed of mannose, xylose, glucose, and glucuronic acid [29], and this GXM could serve as an energy source for Chlamydia.
The in vitro observation that C. gallinacea strains are lost after repeated passages may be due to the depletion of essential metabolites or compounds necessary for C. gallinacea infectivity. This could also explain why inclusions are observed during the initial cultivation of a field sample but disappear during subsequent passages. The C. gallinacea reference strain has been successfully propagated on a BGM cell line for up to 10 passages at the FLI in Germany, in contrast to the results obtained at Anses in France using an identical protocol (standard protocol). This raises the possibility that small variations in sensitive reagents, such as fetal calf serum (which may differ in protein, vitamin, or mineral content), could be critical for C. gallinacea growth. These essential nutrients could be provided in vivo by Trichosporon, a yeast naturally present in poultry, in the context of co-culture, as identified in our study. While yeast extracts are rarely used to culture Chlamydia, they are commonly used for mycoplasmas, which also have small genomes and limited biosynthetic capabilities. Growth factors provided by yeast extracts or fetal calf sera [30] are not standardized and are likely to have varying nutrient content between batches, potentially leading to inconsistent results. Transcriptomic studies could help to identify the necessary supplements to be added, as recently described for Mycoplasma ovipneumoniae [31].
In conclusion, the experimental protocols used to optimize the growth of C. gallinacea did not lead to improved cultivation methods for better inclusion formation and passage propagation. However, despite laboratory constraints that prevented an evaluation of the alternative protocol with the reference strain of C. gallinacea— a limitation of this study—successful propagation of a strain was achieved in a field sample. This sample showed well-formed inclusions that multiplied through passages, consistent with observations in other chlamydial species. The differences in growth patterns cannot be attributed to the initial bacterial load, as their Cq values were similar, or to storage conditions. It is likely that the co-culture of a naturally occurring amphotericin B-resistant yeast in the field sample, which was not eliminated by the antibiotic/antifungal cocktail in the culture medium, influenced the growth of C. gallinacea through passages. Our results suggest that co-culture with a specific fungus may provide favourable conditions for the growth of C. gallinacea in cell culture, as the presence of the fungus may have provided the necessary substrates or conditions for C. gallinacea growth in vitro.
It is now important to investigate how the yeast-depleted strain behaves in vitro and to assess its effect on other C. gallinacea strains. In addition, it would be valuable to determine whether this effect is specific to Trichosporon or whether other yeasts could have a similar effect. Several Chlamydia species with gastrointestinal tropism have recently been described in birds, suggesting host specificity (e.g., C. gallinacea in chickens, Candidatus C. ibidis in flamingos, and C. buteonis in birds of prey). Given their small genomes, Chlamydia species may have evolved to adapt to their environment, in particular to their host’s gut microbiota and available resources. This discovery provides insights into how Chlamydia species may have evolved in relation to their hosts, highlighting the potential role of host microbiota and environmental factors in shaping their specificity and growth strategies.
From a veterinary and public health perspective, it would be important to assess whether and how fungal co-infections in vivo might affect the infectivity of Chlamydia species in their hosts. In particular, a recent case of pneumonia caused by C. psittaci and Cryptococcus infection was identified by WGS in a farmer who had adopted a stray pigeon prior to the onset of symptoms [32]. Further research is needed to clarify this possible synergistic interaction.

Author Contributions

Conceptualization, E.O.-E., K.L. and K.S.; methodology, E.O.-E., F.V., R.A. and V.R.-C.; validation, E.O.-E., K.L. and V.R.-C.; formal analysis, E.O.-E., F.V., R.A., V.R.-C.; investigation, E.O.-E., M.-L.M., F.R., M.M. and C.N.; resources, E.O.-E., M.-L.M., F.R., M.M., C.N. and C.S.; data curation, E.O.-E., F.V. and K.L.; writing—original draft preparation, E.O.-E., K.L., K.S. and G.Z.; writing—review and editing, all; supervision, K.L. and G.Z.; funding acquisition, E.O.-E., M.-L.M. and K.L. All authors have read and agreed to the published version of the manuscript.

Funding

This project received funding from Campus France under the PROJETS ECOS/ANUIES/CONACYT/SEP programme (project M17A01). Erika Ornelas-Eusebio received a doctoral scholarship (No.600997/337987) from the Consejo Nacional de Ciencia y Tecnología (CONACyT; https://www.conacyt.gob.mx/).

Data Availability Statement

All data are available upon request.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
BGMBuffalo Green Monkey
EMEMEagle’s Minimum Essential Medium
FLIFriedrich Loeffler Institute
GXMGlucuronoxylomannan
PCRPolymerase Chain Reaction
WGSWhole Genome Sequencing

Appendix A

Figure A1. Overview of experimental infection protocols conducted to optimize the growth of C. gallinacea by comparing different parameters. Reference strain 08-1274/3_08DC63 of C. gallinacea was used. Once inoculated, cells were subjected to 2 passages using the standard chlamydial growth protocol [12]. (*) and (**): inoculum used for experimental infection protocols 2 (E2) and 3 (E3), respectively (Table A1). (×3 and ×4 correspond to the number of tubes simultaneously inoculated and available for immunostaining and/or passaging).
Figure A1. Overview of experimental infection protocols conducted to optimize the growth of C. gallinacea by comparing different parameters. Reference strain 08-1274/3_08DC63 of C. gallinacea was used. Once inoculated, cells were subjected to 2 passages using the standard chlamydial growth protocol [12]. (*) and (**): inoculum used for experimental infection protocols 2 (E2) and 3 (E3), respectively (Table A1). (×3 and ×4 correspond to the number of tubes simultaneously inoculated and available for immunostaining and/or passaging).
Microorganisms 13 00288 g0a1
Figure A2. Photomicrographs of the BGM, Caco-2 and DF-1 cells inoculated with the titrated 08-1274/3_08DC63 C. gallinacea strain (7.3 × 107 IFU/mL). Immunostaining was performed at 48 h pi (20×). Inclusion size and monolayer integrity were scored from (+) for small, disrupted to (+++) for large, preserved.
Figure A2. Photomicrographs of the BGM, Caco-2 and DF-1 cells inoculated with the titrated 08-1274/3_08DC63 C. gallinacea strain (7.3 × 107 IFU/mL). Immunostaining was performed at 48 h pi (20×). Inclusion size and monolayer integrity were scored from (+) for small, disrupted to (+++) for large, preserved.
Microorganisms 13 00288 g0a2
Figure A3. Photomicrographs of the BGM cells inoculated with the 08-1274/3_08DC63 C. gallinacea strain (from Experiment 1) comparing single and daily centrifugations. Immunostaining was performed at 48 h, 72 h and 96 h pi (20×).
Figure A3. Photomicrographs of the BGM cells inoculated with the 08-1274/3_08DC63 C. gallinacea strain (from Experiment 1) comparing single and daily centrifugations. Immunostaining was performed at 48 h, 72 h and 96 h pi (20×).
Microorganisms 13 00288 g0a3

Appendix B

Table A1. Specifications of growth media, cell maintenance and subculture for the three cell lines included in this study.
Table A1. Specifications of growth media, cell maintenance and subculture for the three cell lines included in this study.
Cell LineGrowth Media and SupplementsCell Incubation
Temperature and CO2 Conditions Used
Maintenance Frequency Per WeekCell Dissociation Process for
Subculture
Density at the Seeding
BGMMinimum Essential Medium
[EMEM, Lonza]
+5% Fetal Calf Serum
+1% L-glutamine
37 °C ± 1 °C
5% CO2
TwiceTrypsinization1.6 × 106/mL
DF-1Dulbecco’s Modified Eagle Medium (Gluc/Pyr/Sodium Bicarbonate)
[DMEM D654, Sigma-Aldrich]
+10% Fetal Calf Serum
+1% L-glutamine
39 °C ± 1 °C
5% CO2
TwiceTrypsinization1.6 × 106/mL
Caco-2Dulbecco’s Modified Eagle Medium
(Gluc/Pyr) [DMEM D654, Thermo Scientific]
+15% Fetal Calf Serum
+1% L-glutamine
+1% Non-Essential Aminoacids 100×
+0.5% Penicillin-Streptomycin (10,000 U/mL)
37 °C ± 1 °C
5% CO2
Once + change of growth medium twice/weekTrypsinization2.5 × 105/mL
Table A2. Summary of the relevant differences between the standard and alternative protocols applied to the C. gallinacea cultivation in this study.
Table A2. Summary of the relevant differences between the standard and alternative protocols applied to the C. gallinacea cultivation in this study.
ProtocolCell Lines Growth Medium After
Inoculation
Number of
Passages After the First
Inoculation
Temperature
Incubation (CO2 Condition)
Centrifugation Step
StandardBGMUltraMDCK with 1% non-Essential Amino Acids, 1% Vitamins and antibiotics/antifungals (25 µg/mL of vancomycin, 10 µg/mL of gentamycin, 2.5 µg/mL of Amphotericin B and 25 U/mL of nystatin)Up to 237 °CSingle initial centrifugation
Alternative BGMEMEM with 20% Fetal Calf Serum, 1% L-glutamine, 3.33 mg/mL D-glucose, 1 mg/mL cycloheximide and antibiotics/antifungals (25 µg/mL of vancomycin, 10 µg/mL of gentamycin, 2.5 µg/mL of Amphotericin B and 25 U/mL of nystatin)Up to 237 °C
(5% CO2)
Daily centrifugation

References

  1. Vorimore, F.; Hölzer, M.; Liebler-Tenorio, E.; Barf, L.-M.; Delannoy, S.; Vittecoq, M.; Wedlarski, R.; Lécu, A.; Scharf, S.; Blanchard, Y.; et al. Evidence for the existence of a new genus Chlamydiifrater gen. nov. inside the family Chlamydiaceae with two new species isolated from flamingo (Phoenicopterus roseus): Chlamydiifrater phoenicopteri sp. nov. and Chlamydiifrater volucris sp. nov. Syst. Appl. Microbiol. 2021, 44, 126200. [Google Scholar] [CrossRef] [PubMed]
  2. Guo, W.; Li, J.; Kaltenboeck, B.; Gong, J.; Fan, W.; Wang, C. Chlamydia gallinacea, not C. psittaci, is the endemic chlamydial species in chicken (Gallus gallus). Sci. Rep. 2016, 6, 19638. [Google Scholar] [CrossRef] [PubMed]
  3. Marchino, M.; Rizzo, F.; Barzanti, P.; Sparasci, O.A.; Bottino, P.; Vicari, N.; Rigamonti, S.; Braghin, S.; Aaziz, R.; Vorimore, F.; et al. Chlamydia Species and Related Risk Factors in Poultry in North-Western Italy: Possible Bird-to-Human Transmission for C. gallinacea. Int. J. Environ. Res. Public Health 2022, 19, 2174. [Google Scholar] [CrossRef] [PubMed]
  4. Donati, M.; Graciotti, C.; Di Francesco, A.; Pavan, G.; Bui, C.; Cevenini, R. Influence of centrifugation on the infectivity of Chlamydia pneumoniae IOL-207. New Microbiol. 1995, 18, 315–318. [Google Scholar] [PubMed]
  5. Onorini, D.; Donati, M.; Marti, H.; Biondi, R.; Levi, A.; Nufer, L.; Prähauser, B.; Rigamonti, S.; Vicari, N.; Borel, N. The influence of centrifugation and incubation temperatures on various veterinary and human chlamydial species. Veter. Microbiol. 2019, 233, 11–20. [Google Scholar] [CrossRef]
  6. Schiller, I.; Schifferli, A.; Gysling, P.; Pospischil, A. Growth characteristics of porcine chlamydial strains in different cell culture systems and comparison with ovine and avian chlamydial strains. Veter. J. 2004, 168, 74–80. [Google Scholar] [CrossRef] [PubMed]
  7. De Puysseleyr, L.; De Puysseleyr, K.; Vanrompay, D.; De Vos, W.H. Quantifying the growth of Chlamydia suis in cell culture using high-content microscopy. Microsc. Res. Tech. 2017, 80, 350–356. [Google Scholar] [CrossRef]
  8. Sachse, K.; Vretou, E.; Livingstone, M.; Borel, N.; Pospischil, A.; Longbottom, D. Recent developments in the laboratory diagnosis of chlamydial infections. Veter. Microbiol. 2008, 135, 2–21. [Google Scholar] [CrossRef]
  9. Stivala, A.; Genovese, C.; Bonaccorso, C.; Di Salvatore, V.; Petronio, G.; Garozzo, A.; Salmeri, M. Comparison of Cell Culture with Three Conventional Polymerase Chain Reactions for Detecting Chlamydophila pneumoniae in Adult’s Pharyngotonsillitis. Comp. Study Curr. Microbiol. 2020, 77, 2841–2846. [Google Scholar] [CrossRef]
  10. Laroucau, K.; Vorimore, F.; Aaziz, R.; Berndt, A.; Schubert, E.; Sachse, K. Isolation of a new chlamydial agent from infected domestic poultry coincided with cases of atypical pneumonia among slaughterhouse workers in France. Infect. Genet. Evol. 2009, 9, 1240–1247. [Google Scholar] [CrossRef] [PubMed]
  11. Sachse, K.; Laroucau, K.; Riege, K.; Wehner, S.; Dilcher, M.; Creasy, H.H.; Weidmann, M.; Myers, G.; Vorimore, F.; Vicari, N.; et al. Evidence for the existence of two new members of the family Chlamydiaceae and proposal of Chlamydia avium sp. nov. and Chlamydia gallinacea sp. nov. Syst. Appl. Microbiol. 2014, 37, 79–88. [Google Scholar] [CrossRef] [PubMed]
  12. Sachse, K.; Grossmann, E.; Jäger, C.; Diller, R.; Hotzel, H. Detection of Chlamydia suis from clinical specimens: Comparison of PCR, antigen ELISA, and culture. J. Microbiol. Methods 2003, 54, 233–238. [Google Scholar] [CrossRef]
  13. Ornelas-Eusebio, E.; Garcia-Espinosa, G.; Vorimore, F.; Aaziz, R.; Durand, B.; Laroucau, K.; Zanella, G. Cross-sectional study on Chlamydiaceae prevalence and associated risk factors on commercial and backyard poultry farms in Mexico. Prev. Veter- Med. 2020, 176, 104922. [Google Scholar] [CrossRef] [PubMed]
  14. Ehricht, R.; Slickers, P.; Goellner, S.; Hotzel, H.; Sachse, K. Optimized DNA microarray assay allows detection and genotyping of single PCR-amplifiable target copies. Mol. Cell. Probes 2006, 20, 60–63. [Google Scholar] [CrossRef]
  15. Laroucau, K.; Aaziz, R.; Meurice, L.; Servas, V.; Chossat, I.; Royer, H.; de Barbeyrac, B.; Vaillant, V.; Moyen, J.L.; Meziani, F.; et al. Outbreak of psittacosis in a group of women exposed to Chlamydia psittaci-infected chickens. Eurosurveillance 2015, 20, 21155. [Google Scholar] [CrossRef]
  16. Zocevic, A.; Vorimore, F.; Marhold, C.; Horvatek, D.; Wang, D.; Slavec, B.; Prentza, Z.; Stavianis, G.; Prukner-Radovcic, E.; Dovc, A.; et al. Molecular characterization of atypical Chlamydia and evidence of their dissemination in different European and Asian chicken flocks by specific real-time PCR. Environ. Microbiol. 2012, 14, 2212–2222. [Google Scholar] [CrossRef] [PubMed]
  17. Staub, E.; Marti, H.; Biondi, R.; Levi, A.; Donati, M.; Leonard, C.A.; Ley, S.D.; Pillonel, T.; Greub, G.; Seth-Smith, H.M.B.; et al. Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin. Sci. Rep. 2018, 8, 5660. [Google Scholar] [CrossRef]
  18. Pruckler, J.M.; Masse, N.; Stevens, V.A.; Gang, L.; Yang, Y.; Zell, E.R.; Dowell, S.F.; Fields, B.S. Optimizing Culture of Chlamydia pneumoniae by Using Multiple Centrifugations. J. Clin. Microbiol. 1999, 37, 3399–3401. [Google Scholar] [CrossRef] [PubMed]
  19. Colombo, A.L.; Padovan, A.C.B.; Chaves, G.M. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin. Microbiol. Rev. 2011, 24, 682–700. [Google Scholar] [CrossRef]
  20. Robinson, K.; Xiao, Y.; Johnson, T.J.; Chen, B.; Yang, Q.; Lyu, W.; Wang, J.; Fansler, N.; Becker, S.; Liu, J.; et al. Chicken Intestinal Mycobiome: Initial Characterization and Its Response to Bacitracin Methylene Disalicylate. Appl. Environ. Microbiol. 2020, 86, e00304-20. [Google Scholar] [CrossRef]
  21. De Boeck, C.; Kalmar, I.; Dumont, A.; Vanrompay, D. Longitudinal monitoring for respiratory pathogens in broiler chickens reveals co-infection of Chlamydia psittaci and Ornithobacterium rhinotracheale. J. Med. Microbiol. 2015, 64, 565–574. [Google Scholar] [CrossRef] [PubMed]
  22. Van Loock, M.; Geens, T.; De Smit, L.; Nauwynck, H.; Van Empel, P.; Naylor, C.; Hafez, H.; Goddeeris, B.; Vanrompay, D. Key role of Chlamydophila psittaci on Belgian turkey farms in association with other respiratory pathogens. Veter. Microbiol. 2005, 107, 91–101. [Google Scholar] [CrossRef] [PubMed]
  23. Loock, M.; Loots, K.; Zande, S.; Heerden, M.; Nauwynck, H.; Goddeeris, B.; Vanrompay, D. Pathogenic interactions between Chlamydophila psittaci and avian pneumovirus infections in turkeys. Veter. Microbiol. 2006, 112, 53–63. [Google Scholar] [CrossRef] [PubMed]
  24. Filardo, S.; Di Pietro, M.; Tranquilli, G.; Sessa, R. Biofilm in Genital Ecosystem: A Potential Risk Factor for Chlamydia trachomatis Infection. Can. J. Infect. Dis. Med. Microbiol. 2019, 2019, 1–6. [Google Scholar] [CrossRef]
  25. Iturrieta-González, I.A.; Padovan, A.C.B.; Bizerra, F.C.; Hahn, R.C.; Colombo, A.L. Multiple Species of Trichosporon Produce Biofilms Highly Resistant to Triazoles and Amphotericin B. PLoS ONE 2014, 9, e109553. [Google Scholar] [CrossRef]
  26. Segrelles-Calvo, G.; Araújo, G.R.D.S.; Llopis-Pastor, E.; Frasés, S. Trichosporon asahii as Cause of Nosocomial Pneumonia in Patient With COVID-19: A Triple Co-infection. Arch. Bronc. 2020, 57, 46–48. [Google Scholar] [CrossRef]
  27. Briones-Claudett, K.H.; Briones-Claudett, M.H.; Cordova Loor, F.J.; Murillo Vasconez, R.A.; Rivera Salas, C.D.R.; Bajaña Huilcapi, C.K.; Estupinan Vargas, D.F.; Rodriguez Garcia, S.E.; Benitez Sólis, J.; Briones Zamora, K.H.; et al. A 71-year-old man from Ecuador with a history of Type 2 diabetes mellitus and severe COVID-19 pneumonia and lung cavitation associated with triple infection with Trichosporon asahii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. J. Investig. Med. High Impact. Case Rep. 2022, 10, 23247096221140250. [Google Scholar] [CrossRef] [PubMed]
  28. Yang, T.; Fu, Y. Trichosporon asahii co-infection with Pneumocystis jiroveci in a renal transplant patient. IDCases 2024, 36, e01951. [Google Scholar] [CrossRef] [PubMed]
  29. Zimbres, A.C.G.; Albuquerque, P.C.; Joffe, L.S.; Souza, T.N.; Nimrichter, L.; Frazão, S.O.; Albuquerque, P.; Fonseca, F.L.; Rodrigues, M.L. A glucuronoxylomannan-like glycan produced by Trichosporon mucoides. Fungal Genet. Biol. 2018, 121, 46–55. [Google Scholar] [CrossRef]
  30. Liu, S.; Yang, W.; Li, Y.; Sun, C. Fetal bovine serum, 20 an important factor affecting the reproducibility of cell experiments. Sci. Rep. 2023, 13, 1942. [Google Scholar]
  31. Wang, X.; Zhang, W.; Hao, Y. Improving Mycoplasma ovipneumoniae culture medium by a comparative transcriptome method. J. Veter. Sci. 2020, 21, e30. [Google Scholar] [CrossRef]
  32. Zhang, A.; Lao, X.; Liang, J.; Xia, X.; Ma, L.; Liang, J. Case Report: Pneumonia Caused by Chlamydia psittaci and Cryptococcus Co-Infection. Infect. Drug Resist. 2024, 17, 845–849. [Google Scholar] [CrossRef]
Figure 1. Photomicrographs of the BGM cells inoculated with 4 C. gallinacea field samples from Mexico (samples A1, A8, Pue6-6 and Pue6-7) and 4 C. gallinacea field samples from Italy (samples 41645-5, 44638-9, 60260-3 and 67320-6). The photomicrographs correspond to the first inoculation, followed by the 1st and 2nd passages. Sample 60260-3 showed atypical development of chlamydial growth from passage 1. Immunostaining was performed on the fixed infected cells at 48 h pi (20×). The first inoculation and passages were performed using the standard or the alternative growth protocol, as indicated in the figures. * indicates the presence of a fungus in the cell culture.
Figure 1. Photomicrographs of the BGM cells inoculated with 4 C. gallinacea field samples from Mexico (samples A1, A8, Pue6-6 and Pue6-7) and 4 C. gallinacea field samples from Italy (samples 41645-5, 44638-9, 60260-3 and 67320-6). The photomicrographs correspond to the first inoculation, followed by the 1st and 2nd passages. Sample 60260-3 showed atypical development of chlamydial growth from passage 1. Immunostaining was performed on the fixed infected cells at 48 h pi (20×). The first inoculation and passages were performed using the standard or the alternative growth protocol, as indicated in the figures. * indicates the presence of a fungus in the cell culture.
Microorganisms 13 00288 g001
Figure 2. Photomicrographs (20×) showing the fungal-like structures contaminating the BGM cells infected with the sample 60260-3 at 24 h pi (A). The fungus was then cultured on Sabouraud’s dextrose agar plates supplemented with 0.5 g/L chloramphenicol (B).
Figure 2. Photomicrographs (20×) showing the fungal-like structures contaminating the BGM cells infected with the sample 60260-3 at 24 h pi (A). The fungus was then cultured on Sabouraud’s dextrose agar plates supplemented with 0.5 g/L chloramphenicol (B).
Microorganisms 13 00288 g002
Table 1. Summary of C. gallinacea-positive field samples (chicken cloacal swabs [3,13] selected for in vitro culture, using either the standard or the alternative protocols). PCR was performed using previously described PCR systems (1 [14] and 2 [15] (except for samples marked with *), which followed [16], before the improvement described in [15]).
Table 1. Summary of C. gallinacea-positive field samples (chicken cloacal swabs [3,13] selected for in vitro culture, using either the standard or the alternative protocols). PCR was performed using previously described PCR systems (1 [14] and 2 [15] (except for samples marked with *), which followed [16], before the improvement described in [15]).
OriginDate of Collection Specimen IdentificationCq Chlamydiaceae
Real-Time PCR 1
Cq
C. gallinacea
Real-Time PCR 2
Culture Protocol
MexicoMay, 201818-2470/Ameca-1 (A1)21.621.6standard
MexicoMay, 201818-2470/Ameca-8 (A8)20.821.4standard
MexicoFebruary, 201818-2470/Pue6-622.423.6standard
MexicoFebruary, 201818-2470/Pue6-725.126.0standard
ItalyMay, 201920-2327/41645-529.619.3 *alternative
ItalyMay, 201920-2327/44638-929.618.2 *alternative
ItalyJuly, 201920-2327/60260-328.027.6alternative
ItalyAugust, 201920-2327/67320-621.120.9alternative
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ornelas-Eusebio, E.; Vorimore, F.; Aaziz, R.; Mandola, M.-L.; Rizzo, F.; Marchino, M.; Nogarol, C.; Risco-Castillo, V.; Zanella, G.; Schnee, C.; et al. Trichosporon asahii: A Potential Growth Promoter for C. gallinacea? Implications for Chlamydial Infections and Cell Culture. Microorganisms 2025, 13, 288. https://doi.org/10.3390/microorganisms13020288

AMA Style

Ornelas-Eusebio E, Vorimore F, Aaziz R, Mandola M-L, Rizzo F, Marchino M, Nogarol C, Risco-Castillo V, Zanella G, Schnee C, et al. Trichosporon asahii: A Potential Growth Promoter for C. gallinacea? Implications for Chlamydial Infections and Cell Culture. Microorganisms. 2025; 13(2):288. https://doi.org/10.3390/microorganisms13020288

Chicago/Turabian Style

Ornelas-Eusebio, Erika, Fabien Vorimore, Rachid Aaziz, Maria-Lucia Mandola, Francesca Rizzo, Monica Marchino, Chiara Nogarol, Veronica Risco-Castillo, Gina Zanella, Christiane Schnee, and et al. 2025. "Trichosporon asahii: A Potential Growth Promoter for C. gallinacea? Implications for Chlamydial Infections and Cell Culture" Microorganisms 13, no. 2: 288. https://doi.org/10.3390/microorganisms13020288

APA Style

Ornelas-Eusebio, E., Vorimore, F., Aaziz, R., Mandola, M.-L., Rizzo, F., Marchino, M., Nogarol, C., Risco-Castillo, V., Zanella, G., Schnee, C., Sachse, K., & Laroucau, K. (2025). Trichosporon asahii: A Potential Growth Promoter for C. gallinacea? Implications for Chlamydial Infections and Cell Culture. Microorganisms, 13(2), 288. https://doi.org/10.3390/microorganisms13020288

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop